This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veterinary Parasitic Infection Diagnostics Development
BioVenic provides veterinary parasitic infection diagnostics development solutions for in vitro detection of parasites—including helminths, protozoa, microsporidia, and ectoparasites—in companion and livestock animals, supporting accurate diagnosis and control of parasitic disease. Our platform covers diagnostic target development, method development across molecular biology, immunology, and biochemistry, custom diagnostic kits and reagents, and validation and optimization of methods, reagents, and kits. We support tailored, one-stop diagnostic programs with fully characterized reference samples, delivering sensitive, specific, and user-friendly tools that meet each client's detection requirements.
Importance of Developing Veterinary Parasitic Infection Diagnostics Solution▼
Veterinary Parasitic Infection Diagnostics Development Services
BioVenic stands as a specialist in pioneering cutting-edge solutions within the realm of veterinary parasitic infection diagnostics development, meticulously attuned to the evolving demands of veterinary medicine. Our service offerings encompass the following domains.
Diagnostics Target Development
We have a deep understanding of animal parasitic infections and provide clients with diagnostic target development services. Based on the parasite species that customers need to detect, we conduct extensive research to identify targets closely related to them.
Diagnostics Method Development
Using our expertise in molecular biology, immunology, and biochemistry, we help clients design and optimize diagnostic tests for the accurate detection and identification of common veterinary parasites. Our tests are developed with a focus on sensitivity, specificity, and user-friendliness.
Custom Kits and Reagents
We offer custom parasite diagnostic kits, including all reagents needed to develop a kit for a specific parasite. Our flexible approach ensures that our customers receive diagnostic tools that meet their specific requirements.
Validation and Optimization
Our one-stop veterinary parasite diagnostic solutions provide customers with validation and optimization services of diagnostic methods, reagents, and kits. We use fully characterized reference samples for extensive validation and optimize diagnostic sensitivity, accuracy, etc. from every aspect.
Common Pathogenic Veterinary Parasites
We provide customers with diagnostics development solutions for a wide range of common veterinary parasites, including worms (such as roundworms, hookworms, whipworms, and tapeworms), protozoans (such as giardia and toxoplasma), and ectoparasites (such as fleas and ticks). Our most popular service options are parasites that infect companion animals such as dogs and cats, and livestock animals such as cattle and sheep. The table below lists some of the common pathogenic parasites.▼
Our Service Flowchart
Related Research
To address the challenges of co-infections and clinical diagnostics for gastrointestinal enteric pathogens, recent molecular research established a multiplex polymerase chain reaction (multiplex PCR) assay capable of the simultaneous differential detection of four major zoonotic protozoans—Giardia duodenalis, Cryptosporidium parvum, Blastocystis spp., and Enterocytozoon bieneusi—in caprine stool samples. Using target-specific primers engineered from conserved genomic sequences retrieved from public databases, the assay conditions were optimized to generate distinct, easily separable electrophoretic amplicon sizes of 1400 bp (G. duodenalis), 755 bp (C. parvum), 573 bp (Blastocystis spp.), and 314 bp (E. bieneusi). Evaluated against 130 field samples from goats alongside single-target PCR assays, the method demonstrated 100.00% diagnostic sensitivity and predictive performance with a analytical limit of detection of > 10^2 copies of cloned pathogenic target DNA, showing no cross-reactivity against other common intestinal parasites. The assay identified field prevalence rates of 23.08% for G. duodenalis, 24.62% for C. parvum, 41.54% for Blastocystis spp., and 12.31% for E. bieneusi, highlighting its scientific value as a highly specific, accurate, and cost-effective molecular tool for high-throughput epidemiological surveillance and livestock health management.
Fig. 1 Multiple PCR detection of four parasites.1
Why Choose Us?
Choosing BioVenic for veterinary parasitic infection diagnostics development offers numerous advantages,
We combine cutting-edge technology with extensive knowledge of parasitology to provide high-quality diagnostic tools.
Our research and custom solutions help clients effectively manage and control veterinary parasitic infections.
Our experience and the broad range of parasite targets ensure that we can provide our clients with custom solutions.
Case Study
Through BioVenic's one-stop parasitic diagnostics pipeline, three complementary platforms to detect a canine parasite were developed and validated—a coproantigen ELISA, a qPCR assay, and a pen-side LAMP test—together with custom kits, reagents, and fully characterized reference panels. As shown in the figure, all three platforms outperformed microscopy in sensitivity and specificity: qPCR reached 97% sensitivity with 100% specificity, while the LAMP test delivered near-laboratory accuracy in under one hour for in-clinic use.
Fig. 2 Performance of Different Detection Platforms
Frequently Asked Questions
Q1: What types of parasitic infection diagnostic platforms can BioVenic assist in developing?
A: BioVenic provides comprehensive development services across multiple technical platforms, including molecular diagnostics (such as PCR, qPCR, and isothermal amplification), immunodiagnostics (such as ELISA, lateral flow test strips, and Western blot), and microfluidic or point-of-care testing (POCT) systems. We tailor the development strategy to your specific target parasites—including protozoa, helminths, and arthropods—and your intended field or clinical application. For specific technology platform selection and feasibility studies, please contact our technical support team to discuss your project goals.
Q2: What sample types are typically required for parasite diagnostic development, and how should they be shipped?
A: Depending on the parasite species and chosen diagnostic format, we work with various matrix types including whole blood, serum, plasma, feces, skin scrapings, and tissue biopsies. Sample preparation requirements, such as minimum volume, fixative/anticoagulant selection, and temperature control (e.g., cold chain or dry ice shipping), vary based on downstream testing requirements. To ensure sample integrity and optimal assay sensitivity, we strongly recommend consulting our technical support staff for detailed sample collection guidelines prior to shipment.
Q3: Can BioVenic help with recombinant antigen or specific antibody preparation for parasite detection assays?
A: Yes, we offer end-to-end solutions that cover target antigen discovery, recombinant protein expression, and polyclonal or monoclonal antibody generation specifically designed for parasite diagnostic assays. Parasitic antigens often present complex structures and cross-reactivity challenges; our development process focuses on screening highly specific epitopes to minimize non-specific binding and cross-reactions with related organisms. Please reach out to our technical support team to evaluate your target biomarker and customize a preparation pipeline.
Q4: How do you address cross-reactivity and sensitivity challenges inherent to parasitic disease diagnostics?
A: Parasitic infections often involve low pathogen loads or shared antigenic structures among related taxa. We optimize assay sensitivity and specificity through rigorous reagent selection, reaction buffer optimization, and assay design validation against closely related species and common co-infections. If you are developing assays for coinfected populations or low-titer samples, please consult our technical support team for customized assay optimization strategies.
Q5: What is the typical timeline and deliverable package for a custom parasite diagnostic development project?
A: Project timelines generally range from several weeks to a few months, depending on the complexity of the diagnostic platform, whether target reagents need to be developed de novo, and the scope of analytical validation required. Key deliverables typically include validated prototype kits or assay protocols, comprehensive development reports, and full analytical performance data. For a custom timeline estimate and detailed project scope based on your target specifications, please contact our technical support representatives.
BioVenic is a trusted leader in the development of animal disease diagnostics. Our veterinary parasitic infection in vitro diagnostics development services provide customers with all the help they need, including target discovery, reagent supply, etc. If you have any needs, please feel free to contact us.
Reference
- Yu, Xingang, et al. "A multiplex PCR assay for simultaneous detection of Giardia duodenalis, Cryptosporidium parvum, Blastocystis spp. and Enterocytozoon bieneusi in goats." Veterinary Sciences 11.9 (2024): 448. https://doi.org/10.3390/vetsci11090448. Used under CC BY 4.0. Without modification.